You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses

Article info

Article menu

Download PDFPDF

Research Article
Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses
Free

Authors

  • Andrew Zloza Rush University Cancer Center 1725 West Harrison Street 60612 Chicago IL USA Department of Immunology/MicrobiologyRush University Medical Center 1750 West Harrison Street 60612 Chicago IL USA PubMed articlesGoogle scholar articles
  • Dae Won Kim Rush University Cancer Center 1725 West Harrison Street 60612 Chicago IL USA PubMed articlesGoogle scholar articles
  • Seunghee Kim-Schulze The Tumor Immunology Laboratory, Department of Surgery, Mount Sinai School of MedicineOne Gustave L. Levy Place 10029 New York NY USA PubMed articlesGoogle scholar articles
  • Michael C Jagoda Rush University Cancer Center 1725 West Harrison Street 60612 Chicago IL USA PubMed articlesGoogle scholar articles
  • Vladia Monsurro Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical CenterNational Institutes of Health 9000 Rockville Pike 20892 Bethesda MD USA Department of Pathology and DiagnosticUniversity of Verona Medical School Verona Italy PubMed articlesGoogle scholar articles
  • Francesco M Marincola Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical CenterNational Institutes of Health 9000 Rockville Pike 20892 Bethesda MD USA Research BranchSidra Medical and Research Centre Doha Qatar PubMed articlesGoogle scholar articles
  • Howard L Kaufman Rutgers Cancer Institute of New Jersey 195 Little Albany Street 08903 New Brunswick NJ USA PubMed articlesGoogle scholar articles
  1. ↵a Andrew_Zloza{at}rush.edu
  2. ↵b kimdaewon{at}chpnet.org
  3. ↵c seunghee.kim-schulze{at}mountsinai.org
  4. ↵d mjagoda2{at}gmail.com
  5. ↵e vladia.monsurro{at}univr.it
  6. ↵f fmarincola{at}sidra.org
  7. ↵g howard.kaufman{at}rutgers.edu
View Full Text

Citation

Zloza A, Kim DW, Kim-Schulze S, et al
Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses
Journal for ImmunoTherapy of Cancer 2014;2:1. doi: 10.1186/2051-1426-2-1

Publication history

  • Received December 4, 2013
  • Accepted January 16, 2014
  • First published January 27, 2014.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2014